Articles Tagged With: ethics
-
Ethics of Lung Transplantation in COVID-19
This article will explore the history and epidemiology of lung transplantation and discuss its application and ethics in the COVID-19 pandemic.
-
Q&A: Ethicists Can Help Clinicians Manage High-Dose Pain Medication Cases
Cases involving high-dose pain medicines can cause conflicts within the clinical team. A palliative care expert explains the ethics of these situations and how to find resolutions.
-
Ethicist: Case Managers Can Fairly and Ethically Handle Patient Refusal to Discharge
In this Q&A, Trevor Bibler, PhD, MTS, assistant professor at the Center for Medical Ethics and Health Policy at Baylor College of Medicine, explains the ethical dilemma of transitioning patients who refuse to leave the hospital. -
The Ethical and Pandemic Problem with Boosters
COVID-19 booster shots are highly controversial from a global perspective. Similar to other industrialized nations, 75% of the people in United States have taken at least one dose, 63% are fully vaccinated, and 25% have received the booster. Yet, more than 30 countries worldwide have vaccinated less than 10% of their population.
-
Neurology Groups Update Position on Stroke and Informed Consent
Experts provide updated ethical guidance on decision-making capacity, emergency treatment, and clinical research.
-
AAN Offers Ethical Guidance on Alzheimer’s Drug
Neurology experts issue caution on costs, side effects regarding the approved-but-controversial Aduhelm.
-
IRBs Face Unique Ethics Questions About Big Data Research
There is a need for ethics review committees to improve oversight capacity for big data research, the authors of a recent paper argued. Researchers assessed the weaknesses of ethics review committees, some of which are not specific to big data research but could be exacerbated by it, and some that are specific to big data research.
-
Needlessly Delayed IRB Approval Raises Ethical Concerns
Delayed study startup times obstruct the enrollment process for prospective participants in clinical trials with a therapeutic intent. That is an ethical concern. Delays in IRB approval hinder enrollment, data collection and analysis, and submissions to regulatory oversight agencies. It takes longer to learn if new therapies are effective and safe. Updated product labeling and product approvals are held up. This delays the opportunity for individuals and society at large to benefit from research.
-
IRBs Use Inconsistent Processes for Informed Consent with Non-English Speakers
Translations, interpretation services, and other necessary accommodations for non-English speakers need to be built into study budgets
-
IRBs Facing Ethically Controversial Questions on Brain Research
The field of brain research sounds a lot like science fiction, but human neural organoids, human neural transplants, and human-animal chimeras all are imminent realities. IRBs are going to be facing some difficult decisions on whether this research can proceed. The authors of a recent report examined these issues.